AI assistant
Sending…
Primis Financial Corp. — Director's Dealing 2018
Oct 24, 2018
33458_dirs_2018-10-24_af37c393-2767-4c79-aa28-a84f121f78e8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Southern National Bancorp of Virginia Inc (SONA)
CIK: 0001325670
Period of Report: 2018-10-24
Reporting Person: Baker Thomas Preston (Chief Credit Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Southern National Bancorp of Virginia Common Stock | 24000 | Direct |
| Southern National Bancorp of Virginia Common Stock | 721 | Indirect |
| Southern National Bancorp of Virginia Common Stock | 5142 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $5.5 | 2019-01-27 | Common Stock (2000) | 2000 | Direct |
| Employee Stock Option (Right to Buy) | $8.02 | 2019-07-29 | Common Stock (2000) | 4000 | Direct |
| Employee Stock Option (Right to Buy) | $7.04 | 2020-07-27 | Common Stock (3000) | 7000 | Direct |
| Employee Stock Option (Right to Buy) | $7.2 | 2021-03-21 | Common Stock (15000) | 22000 | Direct |
| Employee Stock Option (Right to Buy) | $7.92 | 2022-12-05 | Common Stock (5000) | 27000 | Direct |
| Employee Stock Option (Right to Buy) | $9.14 | 2023-06-21 | Common Stock (5000) | 32000 | Direct |
| Employee Stock Option (Right to Buy) | $10.47 | 2024-07-22 | Common Stock (5000) | 37000 | Direct |
| Employee Stock Option (Right to Buy) | $11.43 | 2025-06-19 | Common Stock (4000) | 41000 | Direct |
| Employee Stock Option (Right to Buy) | $11.99 | 2026-06-16 | Common Stock (5000) | 46000 | Direct |
More from Primis Financial Corp.
Regulatory Filings
2026
May 27
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 23
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 4
Regulatory Filings
2026
Jan 29
Director's Dealing
2025
Dec 22